Asia Pacific Private Markets: Liquidity Returns, But Only for Select Deals

…so after two years of drought, the taps are opening again. But only for the right kind of deals.

It’s not a flood. Not even a steady stream. More like a series of carefully calibrated drips — but for Asia Pacific’s private markets, that’s a seismic shift from the deep freeze of 2023 and most of 2024. Data from Preqin and Bain & Company show that private equity and venture capital deal values in the region ticked up 15% year-on-year in Q1 2025, hitting $38.2 billion. That’s still well below the $60 billion+ quarters of 2021, but after consecutive quarters of decline, the signal is unmistakable: institutional investors are dipping their toes back in.

Look, we’re not talking about a return to the ZIRP-fueled frenzy of a few years ago. This is a selective, almost surgical, reopening. The money is flowing into late-stage growth equity, infrastructure, and buyouts of cash-flow-positive companies. Early-stage venture? Still mostly dead money. Real estate? Patchy at best. The message from limited partners (LPs) is clear: bring us something with revenue, preferably profits, and a credible exit pathway.

The Thaw Begins: Q1 Deal Data

The numbers don’t lie, but they need context. According to the latest Reuters analysis, Asia Pacific private equity deal value rose for the first time in seven quarters, driven by a handful of mega-deals in Australia, Japan, and India. Southeast Asia remains a tough sell — regulatory uncertainty and smaller deal sizes keep most global investors on the sidelines.

Japan is the standout. Corporate carve-outs and succession-driven sales are fueling a boom. In February, KKR closed a $2.5 billion buyout of a Japanese industrial components maker — the kind of deal that would have been unthinkable five years ago. India’s story is different: local venture capital funds are raising record amounts, but deployment is cautious. The IPO window there is open, but choosy — only the strongest unicorns are getting out.

And then there’s China. It’s complicated. The government’s crackdown on tech, property, and private tutoring has left deep scars. But selective inbound foreign investment is picking up in advanced manufacturing and green energy — sectors that align with Beijing’s priorities. As James Lim, head of APAC private markets at BlackRock, puts it:

“LPs are asking tough questions about China exposure, but those with the stomach for policy risk are finding compelling entry points. The liquidity is there for funds that can demonstrate local knowledge and exit credibility.”

Meanwhile, the IPO market is showing signs of life again — a critical release valve for private market liquidity. DPC Holdings’ 42% pop on debut earlier this month wasn’t just a feel-good headline; it signaled that public market investors are willing to absorb well-priced listings. That has direct knock-on effects for private equity: a functioning IPO market means GPs can actually return capital to LPs.

Where the Money Is Flowing (And Where It Isn’t)

The selectivity is brutal. Infrastructure — particularly digital infrastructure like data centers and fiber networks — is soaking up capital. Private credit is also booming, with direct lenders stepping in where banks retreated. In Australia, superannuation funds are pouring billions into domestic infrastructure via co-investment vehicles.

On the other side, fintech and consumer tech are still in the penalty box. The B2C startup graveyard across Southeast Asia has spooked everyone. Even in Singapore, which has positioned itself as the region’s safe haven, early-stage fundraising is down 40% from 2022 levels. David Kim, a partner at McKinsey & Company focused on private equity, notes:

“The bar for due diligence has risen dramatically. GPs are spending twice as long on pre-deal work, and LPs are demanding more transparency on portfolio company unit economics. The days of ‘growth at all costs’ are over. Now it’s ‘growth with a path to profitability within 18 months.’”

That shift is reshaping how funds are raised. Secondaries — selling existing LP stakes — have become a favored tool for liquidity. The APAC secondaries market grew to $9 billion in 2024, and is on track to hit $12 billion this year, according to data from Evercore. That’s still small relative to the US, but it’s a lifeline for LPs stuck in overcommitted portfolios from the 2021 vintage.

Exit Hopes and the IPO Window

The big question: can this selective reopening become a broad recovery? It depends on exits. Private equity funds raised enormous amounts in 2020–2021, and those funds are now deep into their holding periods. The pressure to return capital is immense. Without exits, new commitments will stall.

That’s why global IPO markets are being watched like hawks. The APAC region has seen a few high-profile listings this year — Lineage Logistics in Japan, Swiggy in India — but the pipeline is still clogged. Many companies are waiting for better valuations. The recent rally in US equities has helped boost sentiment, but trade tensions and geopolitical risks (the Persian Gulf shipping disruptions add another layer of uncertainty to supply chains and investor confidence) are keeping some deals in the drawer.

Nevertheless, the early signals are positive. Sarah Chen, managing director at Asia Pacific Private Equity Advisors, sees it as a return to fundamentals:

“We’re back to a world where the best managers get the capital and the rest struggle. LPs are doing more co-investments and separate accounts — they want direct control over which assets they own, not just a blind pool. That’s a structural shift that will persist even when liquidity fully returns.”

The data backs her up. According to Bain’s 2025 Asia-Pacific Private Equity Report, co-investments now account for 22% of all PE capital deployed in the region, up from 12% in 2020.

What This Means for LPs and GPs

For limited partners, this selective environment is actually a welcome development. During the boom years, capital was chasing too many deals, driving up valuations and compressing returns. Now, discipline is back. The J-curve might be steeper, but the eventual IRR should be healthier.

For general partners, the message is: differentiate or die. A generic pan-Asia fund will struggle to raise its next vehicle. Sector-specialized or geographically focused funds — say, Japan industrials or Indian healthcare — have a much better shot. And proof of exit execution is non-negotiable. GPs that can show they’ve successfully taken companies public or sold to strategic buyers will win the allocation.

There’s also a lesson for the secondary market: the volume of transactions is increasing, but pricing is polarized. Top-quartile funds trade near par; the rest are taking double-digit haircuts. That’s creating opportunities for specialist secondary buyers, but it’s also forcing underperformers to rethink their strategies.

One trend to watch: sovereign wealth funds and large pension funds are increasingly building in-house direct investment teams, cutting out external managers. The Canadian and Australian models are coming to Asia. That could reshape the fundraising landscape entirely if it gains momentum.

The next 12 months will tell us whether this is a genuine recovery or just a head-fake. If the US economy stays resilient and interest rates edge lower, capital should continue flowing into APAC private markets. If recession fears spike again, the taps could tighten just as fast. But for now, the patient is off the ventilator. It’s walking, slowly, with a cane.

And that’s a better prognosis than anyone would have predicted a year ago.